Menu UF Health Home Menu
 

TL1 Training Grant

Program Overview

TL1 2016 with Wayne McCormack

TL1 Trainees with Drs. David Nelson, Wayne McCormack, and Tom Pearson

  • Complete the CTS Interdisciplinary Concentration
  • At least one CTS Specific Aim required for dissertation project
  • TL1 Teams and TL1 Mentoring Teams
  • Submission of a clinical/translational research manuscript for publication
  • Present research at annual national Translational Science conference (ACTS) during TL1 funding period
  • Present research at annual CTSI Annual Research Symposium
  • Semi-annual progress reports

The CTSI TL1 Predoctoral Training Program provides predoctoral trainees with the skills required to develop a career in multidisciplinary clinical and translational research.  The program uses a team-science approach and provides mentoring and didactic training for predoctoral students performing clinical and/or translational research in health-related fields at UF.

TL1 trainees will initially receive one year of funding, including a stipend (current year level: $23,376*), tuition waiver and health insurance; $2,500 for lab and training-related expenses; and a $1,500 travel allowance to attend and present research at the annual Translational Science conference.  A second year of funding may be awarded based on performance, progress and available funding.

Contact the program with any questions at training@ctsi.ufl.edu.

*If a TL1 trainee’s current stipend is above $23,376, their mentor should supplement the stipend from non-federal funds to the original stipend level.

TL1 Application Timeline

March 24 – Applications due
April 14 – Finalists for interviews notified
April 25-26 – Team interviews
May 5 – Awardees announced

Eligibility Requirements

  1. Applicants must be U.S. citizens or permanent residents per NIH policy and entering their second or third year of doctoral graduate study. Students from populations underrepresented in the biomedical, clinical, behavioral and social sciences are encouraged to apply (more information).
  2. Doctoral students from the following partner graduate programs spanning 11 colleges are eligible to apply.  Additional partner programs can be added, so applications from students performing human health-related research in other relevant graduate programs may be considered.
    • Agricultural & Life Sciences: Nutritional Sciences
    • Dentistry: DMD-PhD Program
    • Engineering: Biomedical Engineering, Materials Science & Engineering, Electrical Engineering
    • Health & Human Performance: Applied Physiology & Kinesiology, Health Education & Behavior
    • Journalism & Communications: Mass Communication
    • Liberal Arts & Sciences: Chemistry
    • Medicine: Biomedical Sciences Graduate Program (Biochemistry & Molecular Biology, Cancer Biology, Genetics, Immunology & Microbiology, Molecular Cell Biology, Neuroscience, Physiology & Pharmacology), MD-PhD Program, Health Outcomes & Policy
    • Nursing: Nursing Science
    • Pharmacy: Medicinal Chemistry, Pharmaceutics, Pharmacodynamics, Pharmaceutical Outcomes and Policy, Clinical Pharmaceutical Sciences
    • Public Health & Health Professions: Clinical and Health Psychology, Communication Science & Disorders, Public Health, Rehabilitation Sciences
    • Veterinary Medicine: Veterinary Medical Sciences (Physiological Science, Infectious Diseases & pathology, Large Animal Clinical Science, Small Animal Clinical Science)
    • Multi-College Programs: Biostatistics, Epidemiology, Genetics & Genomics
  3. Applicants must apply in the first or second year of Ph.D. studies, prior to defending their dissertation proposal.
  4. Applicants should have strong academic credentials and good communication skills.
  5. Applicants must be able to commit to all course and research training requirements of the training program.
  6. Applicants must propose a research project relevant to human health, which should include at least one component of clinical and/or translational research as defined by the NIH.
  7. Applicants should demonstrate interest in developing a career in multidisciplinary, translational biomedical research.
  8. Applicants must have strong mentor support.

Program Requirements

TL1 Trainees must:

  • Complete the Clinical & Translational Science Interdisciplinary Concentration;
  • Present their research at the annual Translational Science (Association for Clinical & Translational Science) conference during each year of TL1 funding, and at the annual CTSI Research Day each year until graduation.
  • Design at least one CTS Specific Aim for dissertation project
  • Participate in a TL1 Team
  • Submit for publication in a peer-reviewed journal a CTS review paper relevant to team research topic
  • Submit semi-annual progress reports

TL1 Teams

TL1 Trainees will be expected to identify at least one other TL1 Trainee as a research collaborator.  TL1 Team members must be pursuing their PhD degree in different PhD programs, preferably in different colleges.

Application Process

Applicants must assemble an application packet that includes a completed TL1 application form and supporting materials, which include applicant statements; a research plan for the proposed research project, which must have both clinical/ translational and basic science components; and supporting materials from proposed TL1 Team mentors.  Finalists will be interviewed by the TL1 Advisory Committee.  New applications must be submitted electronically to sgard@ufl.edu by 5:00 p.m. on Friday, March 24, 2017.  Paper documents will not be accepted.

 

Definitions

  1. Clinical Research: Patient-oriented research, including epidemiologic and behavioral studies, outcomes research, and health services research. Patient-oriented research is research conducted with human subjects (or on material of human origin such as tissues, specimens, and cognitive phenomena) in which a researcher directly interacts with human subjects. It includes research on mechanisms of human disease, therapeutic interventions, clinical trials, and development of new technologies, but does not include in vitro studies using human tissues not linked to a living individual. Studies falling under 45 CFR 46.101(b) (4) are not considered clinical research for purposes of this definition. (Source: http://grants.nih.gov/grants/glossary.htm)
  2. Translational Research: Translational research includes two areas of translation. One is the process of applying discoveries generated during research in the laboratory, and in preclinical studies, to the development of trials and studies in humans. The second area of translation concerns research aimed at enhancing the adoption of best practices in the community. Cost-effectiveness of prevention and treatment strategies is also an important part of translational science. (Source: http://grants.nih.gov/grants/glossary.htm)
  3. Permanent Resident: someone who has been granted authorization to live and work in the United States on a permanent basis. As proof of that status, a person is granted a permanent resident card, commonly called a “green card.” (Source: US Citizen and Immigration Services)